Intrathecal baclofen therapy: Benefits and complications

References

• Albright, A. L. (1996). Baclofen in the treatment of cerebral palsy. Journal of Child Neurology, 11, 77–83. doi: 10.1177/088307389601100202
   PubMed Web of Science ®Google Scholar
• Albright, A. L., Barron, W. B., Fasick, M. P., Polinko, P., Janosky, J. (1993). Continuous intrathecal baclofen infusion for spasticity of cerebral origin. Journal of the American Medical Association, 270, 2475–2477.
   PubMed Web of Science ®Google Scholar
• Albright, A. L., Cervi, A., Singletary, J. (1991). Intrathecal baclofen for spasticity in cerebral palsy. Journal of the American Medical Association, 265, 1418–1422.
   PubMed Web of Science ®Google Scholar
• Almeida, G. L., Campbell, S. K., Girolami, G. L., Penn, R. D., Corcos, D. M. (1997). Multidimensional assessment of motor function in a child with cerebral palsy following intrathecal administration of baclofen. Physical Therapy, 77, 751–764.
   Google Scholar
• Armstrong, R. W., Steinbok, P., Cochrane, D. D., Kube, S. D., Fife, S. E., Farrell, K. (1997). Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. Journal of Neurosurgery, 87, 409–414. doi: 10.3171/jns.1997.87.3.0409
   PubMed Web of Science ®Google Scholar
• Awaad, Y., Tayem, H., Munoz, S., Ham, S., Michon, A. M., Awaad, R. (2003). Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. Journal of Child Neurology, 18, 26–34. doi: 10.1177/08830738030180010701
   PubMed Web of Science ®Google Scholar
• Becker, R., Alberti, O., Bauer, B. L. (1997). Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. Journal of Neurology, 244, 160–166. doi: 10.1007/s004150050067
   PubMed Web of Science ®Google Scholar
• Borowski, A., Littleton, A. G., Borkhuu, B., Presedo, A., Shah, S., Dabney, K. W., Miller, F. (2010). Complications of intrathecal baclofen pump therapy in pediatric patients. Journal of Pediatric Orthopaedics, 30, 76–81. doi: 10.1097/BPO.0b013e3181c6b257
   PubMed Web of Science ®Google Scholar
• Coffey, J. R., Cahill, D., Steers, W., Park, T. S., Ordia, J., Meythaler, J., Leibrock, L. G. (1993). Intrathecal baclofen for intractable spasticity of spinal origin: Results of a long-term multicenter study. Journal of Neurosurgery, 78, 226–232. doi: 10.3171/jns.1993.78.2.0226
   PubMed Web of Science ®Google Scholar
• Davidoff, R. A. (1985). Antispasticity drugs: Mechanisms of action. Annals of Neurology, 17, 107–116. doi: 10.1002/ana.410170202
   PubMed Web of Science ®Google Scholar
• Dralle, D., Müller, H., Zierski, J., Klug, N. (1985). Intrathecal baclofen for spasticity [Letter to the editor]. Lancet, 326, 1003. doi: 10.1016/S0140-6736(85)90541-0
   Google Scholar
• Gerszten, P. C., Albright, A. L., Barry, M. J. (1997). Effect on ambulation of continuous intrathecal baclofen infusion. Pediatric Neurosurgery, 27, 40–44. doi: 10.1159/000121223
   PubMedGoogle Scholar
• Gerszten, P. C., Albright, A. L., Johnstone, G. F. (1998). Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. Journal of Neurosurgery, 88, 1009–1013. doi: 10.3171/jns.1998.88.6.1009
   Google Scholar
• Gianino, J. M., York, M. M., Paice, J. A., Shott, S. (1998). Quality of life: Effect of reduced spasticity from intrathecal baclofen. Journal of Neuroscience Nursing, 30, 47–54. doi: 10.1097/01376517-199802000-00006
   PubMedGoogle Scholar
• Gilmartin, R., Bruce, D., Storrs, B. B., Abbott, R., Krach, L., Ward, J., Nadell, J. (2000). Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial. Journal of Child Neurology, 15, 71–77. doi: 10.1177/088307380001500201
   PubMed Web of Science ®Google Scholar
• Gooch, J. L., Oberg, W. A., Grams, B., Ward, L. A., Walker, M. L. (2003). Complications of intrathecal baclofen pumps in children. Pediatric Neurosurgery, 39, 1–6. doi: 10.1159/000070870
   PubMed Web of Science ®Google Scholar
• Gooch, J. L., Oberg, W. A., Grams, B., Ward, L. A., Walker, M. L. (2004). Care provider assessment of intrathecal baclofen in children. Developmental Medicine & Child Neurology, 46, 548–552. doi: 10.1111/j.1469-8749.2004.tb01013.x
   PubMedGoogle Scholar
• Grabb, P. A., Guin-Renfroe, S., Meythaler, J. M. (1999). Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity. Neurosurgery, 45, 833–836; 837. doi: 10.1097/00006123-199910000-00020
   PubMed Web of Science ®Google Scholar
• Graham, H. K., Selber, P. (2003). Musculoskeletal aspects of cerebral palsy. Journal of Bone & Joint Surgery, British Volume, 85, 157–166. doi: 10.1302/0301-620X.85B2.14066
   PubMedGoogle Scholar
• Green, L. B., Nelson, V. S. (1999). Death after acute withdrawal of intrathecal baclofen: Case report and literature review. Archives of Physical Medicine and Rehabilitation, 80, 1600–1604. doi: 10.1016/S0003-9993(99)90337-4
   PubMedGoogle Scholar
• Krach, L. (1999). Complications associated with continuous infusion of intrathecal baclofen. Developmental Medicine & Child Neurology, 41(s80), 12.
   Google Scholar
• Krach, L. E. (2001). Pharmacotherapy of spasticity: Oral medications and intrathecal baclofen. Journal of Child Neurology, 16, 31–36. doi: 10.1177/088307380101600106
   PubMed Web of Science ®Google Scholar
• Meythaler, J. M., Guin-Renfroe, S., Law, C., Grabb, P., Hadley, M. N. (2001). Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Archives of Physical Medicine and Rehabilitation, 82, 155–161. doi: 10.1053/apmr.2001.19246
   PubMed Web of Science ®Google Scholar
• Middel, B., Kuipers-Upmeijer, H., Bouma, J., Staal, M., Oenema, D., Postma, T., Stewart, R. (1997). Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. Journal of Neurology, Neurosurgery & Psychiatry, 63, 204–209. doi: 10.1136/jnnp.63.2.204
   PubMed Web of Science ®Google Scholar
• Murphy, N. A., Irwin, M. C. N., Hoff, C. (2002). Intrathecal baclofen therapy in children with cerebral palsy: Efficacy and complications. Archives of Physical Medicine and Rehabilitation, 83, 1721–1725. doi: 10.1053/apmr.2002.36068
   PubMed Web of Science ®Google Scholar
• Nuttin, B., Ivanhoe, C., Albright, L., Dimitrijevic, M., Saltuari, L. (1999). Intrathecal baclofen therapy for spasticity of cerebral origin: Cerebral palsy and brain injury. Neuromodulation, 2, 120–132. doi: 10.1046/j.1525-1403.1999.00120.x
   PubMed Web of Science ®Google Scholar
• Ochs, G., Naumann, C., Dimitrijevic, M., Sindou, M. (1999). Intrathecal baclofen therapy for spinal origin spasticity: Spinal cord injury, spinal cord disease, and multiple sclerosis. Neuromodulation, 2, 108–119. doi: 10.1046/j.1525-1403.1999.00108.x
   Google Scholar
• Ordia, J. I., Fischer, E., Adamski, E., Spatz, E. L. (1996). Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. Journal of Neurosurgery, 85, 452–457. doi: 10.3171/jns.1996.85.3.0452
   PubMed Web of Science ®Google Scholar
• Paley, D. (1990). Problems, obstacles, and complications of limb lengthening by the Ilizarov technique. Clinical Orthopaedics & Related Research, 250, 81–104.
   PubMed Web of Science ®Google Scholar
• Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., Galuppi, B. (1997). Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine & Child Neurology, 39, 214–223.
   PubMed Web of Science ®Google Scholar
• Penn, R., Kroin, J. (1984). Continuous intrathecal baclofen alleviates spinal cord spasticity [Letter to the editor]. Lancet, 1078, 125–127.
   Google Scholar
• Penn, R. D., York, M. M., Paice, J. A. (1995). Catheter systems for intrathecal drug delivery. Journal of Neurosurgery, 83, 215–217. doi: 10.3171/jns.1995.83.2.0215
   PubMed Web of Science ®Google Scholar
• Pirpiris, M., Graham, H. (2001). Management of spasticity in childhood. Barnes M., Johnson G., Upper motor neurone syndrome and spasticity (266–305). Cambridge, UK: Cambridge University Press.
   Google Scholar
• Samson-Fang, L., Gooch, J., Norlin, C. (2000). Intrathecal baclofen withdrawal simulating neuroepileptic malignant syndrome in a child with cerebral palsy. Developmental Medicine & Child Neurology, 42, 561–565. doi: 10.1017/S0012162200001055
   Google Scholar
• Ward, A., Hayden, S., Dexter, M., Scheinberg, A. (2009). Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment. Journal of Paediatrics and Child Health, 45, 720–726.
   PubMed Web of Science ®Google Scholar
• Zierski, J., Müller, H., Dralle, D., Wurdinger, T. (1988). Implanted pump systems for treatment of spasticity. Acta Neurochirurgica Supplementum, 43, 94–99.
   Google Scholar